Skip to main content
. Author manuscript; available in PMC: 2015 Nov 12.
Published in final edited form as: Vaccine. 2014 Sep 27;32(48):6469–6477. doi: 10.1016/j.vaccine.2014.09.034

Figure 4. Assessment of vaccine tolerability by visual analogue pain score (VAPS).

Figure 4

Immediately post immunization each subject scored their injection site pain in the range from from 0 (no pain) to 10 (worst imaginable pain). Shown are the injection site VAPS scores (mean + SEM) for each vaccine group immediately following each immunization. *p<0.05